Literature DB >> 1989848

Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.

D Maiter1, L E Underwood, J B Martin, J I Koenig.   

Abstract

Administration of monosodium glutamate (MSG) to neonatal rodents produces permanent lesions of hypothalamic arcuate neurons that secrete GH-releasing hormone (GHRH). The present study was intended to determine the consequences of GHRH deficiency on the pulsatile GH secretory pattern and growth in MSG-treated female rats and to compare these effects with those observed in male littermates. Male and female rats were injected with MSG [4 mg/g body wt (BW), sc] or saline (controls) on days 2, 4, 6, 8, and 10 after birth. Immunoreactive GHRH concentrations were decreased in the hypothalamus (by 60%) and in the median eminence (by 95%) of adult male and female MSG-treated rats. In contrast, somatostatin concentrations were unaffected. BW and linear growth were severely impaired in male MSG-treated rats, but in MSG-lesioned females BW was not different from controls, and the attenuation of longitudinal growth was less severe and the obesity more pronounced than in males. These sex differences occurred despite similar reductions (by 55%) in serum insulin-like growth factor I concentrations in male and female MSG-treated rats. MSG treatment also produced decreases in pituitary wt and GH content (by 60%), independent of sex. Pulsatile GH secretion was studied by serial blood sampling of chronically cannulated, freely moving rats. Plasma GH patterns were analyzed by the PULSAR program. Compared to controls, treatment with MSG led to a marked inhibition (by 90%) of GH secretion in both sexes. Significant reductions in GH pulse amplitude (-95%) and pulse duration (-62%) were observed in males, whereas pulse amplitude (-85%), pulse frequency (-67%), and baseline GH concentrations (-80%) were markedly reduced in females. The GH responses to an iv bolus injection of rat GHRH (1 microgram/rat) was severely blunted in both male and female MSG-treated rats. This study demonstrates that GHRH deficiency in female rats results in a marked inhibition of GH pulses, as in males, but also causes severe and sex-specific reductions in GH basal secretion and pulse frequency. These observations suggest that hypothalamic GHRH secretion in female rats is more continuous than in males and is a determinant of the elevated interpulse secretion of GH. Moreover, body wt and linear growth are less severely affected by arcuate lesions in female animals, compared to males. These sex-related differences in growth rates may result in part from the tendency of female MSG-lesioned rats to become more obese than males, and the development of obesity, in turn, may antagonize the factors that tend to slow linear growth.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1989848     DOI: 10.1210/endo-128-2-1100

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  The dual effect of isoproterenol on insulin release is suppressed in pancreatic islets from hypothalamic obese rats.

Authors:  Anderson Carlos Marçal; Sabrina Grassiolli; Diego Neves da Rocha; Marcelo Aguilar Puzzi; Clarice Gravena; Dionízia Xavier Scomparin; Paulo Cezar de Freitas Mathias
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion.

Authors:  David L Carbone; Damian G Zuloaga; Ryoko Hiroi; Chad D Foradori; Marie E Legare; Robert J Handa
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

3.  Impaired muscarinic type 3 (M3) receptor/PKC and PKA pathways in islets from MSG-obese rats.

Authors:  Rosane Aparecida Ribeiro; Sandra Lucinei Balbo; Letícia Prates Roma; Rafael Ludemann Camargo; Luiz Felipe Barella; Emerielle Cristine Vanzela; Paulo Cesar de Freitas Mathias; Everardo Magalhães Carneiro; Antonio Carlos Boschero; Maria Lúcia Bonfleur
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

4.  Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells.

Authors:  Philip Zeitler; Gamini Siriwardana
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

5.  Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses.

Authors:  C A Jaffe; R D Friberg; A L Barkan
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Duodenal-jejunal bypass restores insulin action and βeta-cell function in hypothalamic-obese rats.

Authors:  Maria Lúcia Bonfleur; Rosane Aparecida Ribeiro; Audrei Pavanello; Raul Soster; Camila Lubaczeuski; Allan Cezar Faria Araujo; Antonio Carlos Boschero; Sandra Lucinei Balbo
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

7.  Impaired sympathoadrenal axis function contributes to enhanced insulin secretion in prediabetic obese rats.

Authors:  Ana Eliza Andreazzi; Sabrina Grassiolli; Paula Beatriz Marangon; Adriana Gallego Martins; Júlio Cézar de Oliveira; Rosana Torrezan; Clarice Gravena; Raúl Marcel González Garcia; Paulo Cezar de Freitas Mathias
Journal:  Exp Diabetes Res       Date:  2011-08-16

8.  Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity.

Authors:  Kate S Collison; Nadine J Makhoul; Marya Z Zaidi; Soad M Saleh; Bernard Andres; Angela Inglis; Rana Al-Rabiah; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

9.  Vagotomy ameliorates islet morphofunction and body metabolic homeostasis in MSG-obese rats.

Authors:  C Lubaczeuski; S L Balbo; R A Ribeiro; J F Vettorazzi; J C Santos-Silva; E M Carneiro; M L Bonfleur
Journal:  Braz J Med Biol Res       Date:  2015-02-24       Impact factor: 2.590

10.  Oral Metformin Treatment Counteracts Adipoinsular Axis Dysfunction in Hypothalamic Obese Rats.

Authors:  Daniel Castrogiovanni; Luisina Ongaro; Guillermina Zuburía; Andrés Giovambattista; Eduardo Spinedi
Journal:  Int Sch Res Notices       Date:  2015-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.